Kayte Spector-Bagdady, is an associate professor of obstetrics and gynecology at the University of Michigan. As soon as the genetic testing company 23andMe filed for bankruptcy on March 23, 2025, ...

On March 23, 2025, genetic testing company 23andMe announced it filed for bankruptcy — sparking a firestorm of articles and online posts advising consumers to delete their personal data in order to ...

Some important news for millions of 23andMe customers: The genetic testing company notified customers on Sunday that they now have until July 14 to file potential claims as the company navigates ...

23andMe, a standard-bearer for the at-home health movement, announced on March 23 that it has filed for Chapter 11 bankruptcy to facilitate a sale, prompting many of ...

Reporter Alexi Horowitz-Ghazi's Aunt Vovi signed up for 23andMe back in 2017, hoping to learn more about the genetic makeup of her ancestors. Vovi was one of over 15 million 23andMe customers who sent ...

Genetics testing company 23andMe on Monday announced a deal to be acquired by biotechnology company Regeneron. The $256 million sale is subject to court oversight, and still needs approval. The sale ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that ...

“I mentioned to a co-worker that I just found out I had the breast cancer gene,” a woman told me a few years ago. “The next thing I knew, everyone in the office was asking me, ‘How are you?’ When the ...

Genetic testing company 23andMe filed for bankruptcy in March. Regeneron Pharmaceuticals on Monday announced plans to purchase genetic testing company 23andMe for $256 million. The New York-based ...

23andMe, a standard-bearer for the at-home health movement, announced on March 23 that it has filed for Chapter 11 bankruptcy to facilitate a sale, prompting many of ...